PLOD1 and polycystic ovary syndrome: The evidence of the direct effects of adropin on PCOS is lacking, but these effects could be mediated indirectly through adropin’s substantial mitigation of the IR and glycemic control, which positively impacted the plasma LH and androgen levels [22].